Cargando…

Calcified Middle Cranial Fossa Mass

A 21-year-old male presented for evaluation of transient loss of consciousness and was found to have a hyperdense mass in the left middle fossa. He underwent craniotomy for tumor resection. Intra- and extradural invasion was noted. Gross total resection was achieved. Pathology demonstrated a densely...

Descripción completa

Detalles Bibliográficos
Autores principales: Botros, James, Hatanpaa, Kimmo, Isaacson, Brandon, Barnett, Samuel L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332251/
https://www.ncbi.nlm.nih.gov/pubmed/28255529
http://dx.doi.org/10.1055/s-0037-1598112
_version_ 1782511509604139008
author Botros, James
Hatanpaa, Kimmo
Isaacson, Brandon
Barnett, Samuel L.
author_facet Botros, James
Hatanpaa, Kimmo
Isaacson, Brandon
Barnett, Samuel L.
author_sort Botros, James
collection PubMed
description A 21-year-old male presented for evaluation of transient loss of consciousness and was found to have a hyperdense mass in the left middle fossa. He underwent craniotomy for tumor resection. Intra- and extradural invasion was noted. Gross total resection was achieved. Pathology demonstrated a densely cellular neoplasm with predominately spindle cell morphology in a collagen-containing stroma, areas of vascular proliferation, focal mineralization, and regions of cartilage formation. High mitotic index and regions of necrosis were seen. Based on the final diagnosis of osteosarcoma, the patient was referred for chemotherapy and radiation. Intracranial osteosarcoma is a nonmeningiomatous mesenchymal tumor. Most osteosarcomas are meningeal-based and supratentorial. Presentation depends on tumor location and may include focal neurologic deficits, cranial neuropathy, seizures, or symptoms of increased intracranial pressure. Given the relative rarity of intracranial osteosarcoma, there are no established guidelines for treatment, and therapy is guided by experience with systemic osteosarcoma. Gross total resection is recommended whenever feasible. Both chemotherapy and radiation therapy are used as adjuvant therapy. Regardless of treatment, osteosarcoma remains a highly aggressive malignancy with a poor prognosis. Morbidity and mortality may be the result of local recurrence or development of pulmonary or skeletal metastasis.
format Online
Article
Text
id pubmed-5332251
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-53322512017-03-02 Calcified Middle Cranial Fossa Mass Botros, James Hatanpaa, Kimmo Isaacson, Brandon Barnett, Samuel L. J Neurol Surg Rep A 21-year-old male presented for evaluation of transient loss of consciousness and was found to have a hyperdense mass in the left middle fossa. He underwent craniotomy for tumor resection. Intra- and extradural invasion was noted. Gross total resection was achieved. Pathology demonstrated a densely cellular neoplasm with predominately spindle cell morphology in a collagen-containing stroma, areas of vascular proliferation, focal mineralization, and regions of cartilage formation. High mitotic index and regions of necrosis were seen. Based on the final diagnosis of osteosarcoma, the patient was referred for chemotherapy and radiation. Intracranial osteosarcoma is a nonmeningiomatous mesenchymal tumor. Most osteosarcomas are meningeal-based and supratentorial. Presentation depends on tumor location and may include focal neurologic deficits, cranial neuropathy, seizures, or symptoms of increased intracranial pressure. Given the relative rarity of intracranial osteosarcoma, there are no established guidelines for treatment, and therapy is guided by experience with systemic osteosarcoma. Gross total resection is recommended whenever feasible. Both chemotherapy and radiation therapy are used as adjuvant therapy. Regardless of treatment, osteosarcoma remains a highly aggressive malignancy with a poor prognosis. Morbidity and mortality may be the result of local recurrence or development of pulmonary or skeletal metastasis. Georg Thieme Verlag KG 2017-01 /pmc/articles/PMC5332251/ /pubmed/28255529 http://dx.doi.org/10.1055/s-0037-1598112 Text en © Thieme Medical Publishers
spellingShingle Botros, James
Hatanpaa, Kimmo
Isaacson, Brandon
Barnett, Samuel L.
Calcified Middle Cranial Fossa Mass
title Calcified Middle Cranial Fossa Mass
title_full Calcified Middle Cranial Fossa Mass
title_fullStr Calcified Middle Cranial Fossa Mass
title_full_unstemmed Calcified Middle Cranial Fossa Mass
title_short Calcified Middle Cranial Fossa Mass
title_sort calcified middle cranial fossa mass
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332251/
https://www.ncbi.nlm.nih.gov/pubmed/28255529
http://dx.doi.org/10.1055/s-0037-1598112
work_keys_str_mv AT botrosjames calcifiedmiddlecranialfossamass
AT hatanpaakimmo calcifiedmiddlecranialfossamass
AT isaacsonbrandon calcifiedmiddlecranialfossamass
AT barnettsamuell calcifiedmiddlecranialfossamass